VX09-809-102 Cohort 3: Phase 2, Multicenter, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of VX809 Alone and in Combination with VX-770

Project: Research project

Project Details

StatusFinished
Effective start/end date9/1/12 → 8/31/13

Funding

  • Vertex Pharmaceuticals Incorporated (VX09-809-102 Cohort 3)